APOTHEEK DEWAELE - IDE
ActiveAPOTHEEK DEWAELE - IDE has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €624k and a net result of €31k. Equity remains stable across the filed fiscal years (±0.8% per year). Its solvency ranks better than 70% of 10310 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
67
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability57▲+35
Solvency83▲+1
Growth69▲+17
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity tight (current ratio 1.27 against 1.13 in 2024; short-term debt: 41.7% and cash: 10.6% of total assets), and 42.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
57.8%
Return on assets
2.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-05-2026, 86 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
86 d early
2024
84 d early
2023
84 d early
2022
89 d early
2021
90 d early
2020
93 d early
2019
88 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
€2.42M▲ 5.8%
2024 · €2.29M
2024: €2.29M
2024 → 2025
EBIT margin
2.1%▲ 3.6pp
2024 · -1.4%
2024: -1.4%
2024 → 2025
Net result
€31k
2024 · €-54k
2018: €19k
2019: €8k
2020: €74k
2021: €-29k
2022: €9k
2023: €28k
2024: €-54k
2018 → 2025
Working capital
€123k▲ 112%
2024 · €58k
2018: €86k
2019: €59k
2020: €104k
2021: €76k
2022: €72k
2023: €93k
2024: €58k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€2.29M€2.42M▲ 5.8%
Equity€610k-€619k▲ 1.4%€646k▲ 4.5%€593k▼ 8.3%€624k▲ 5.3%
Operating result€-12k-€21k€50k▲ 139%€-33k€52k
Net result€-29k-€9k€28k▲ 216%€-54k€31k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €52k after a loss of €33k in 2024, the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.08M
Fixed assets
€506k▼ 7.7%
Current assets
€574k▲ 15.3%
Equity and liabilities €1.08M
Equity
€624k▲ 5.3%
Debt
€456k▲ 0.5%
The debt ratio falls from 43.3% to 42.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€110k▲
2024 · €23k
Cash flow
€90k▲
2024 · €2k
Solvency
57.8%▲
2024 · 56.7%
Current ratio
1.27▲
2024 · 1.13
Quick ratio
0.99▲
2024 · 0.85
Debt / equity
0.73▼
2024 · 0.76
ROE
5.0%▲
2024 · -9.0%
ROA
2.9%▲
2024 · -5.1%
Interest coverage
5.24▲
2024 · 1.02
Debt
€456k▲
2024 · €453k
Debt ≤ 1 year
€451k▲
2024 · €440k
Debt > 1 year
€5k▼
2024 · €14k
Income taxes
€4k▲
2024 · €527
Staff costs
€33k▲
2024 · €30k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.05M€1.08M▲
Fixed assets21/28€548k€506k▼
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€548k€506k▼
Land and buildings22€498k€358k▼
Plant, machinery and equipment23€51k€138k▲
Furniture and vehicles24€0€10k▲
Financial fixed assets28€81€81=
Current assets29/58€498k€574k▲
Stocks and contracts in progress3€125k€128k▲
Stocks30/36€125k€128k▲
Amounts receivable within one year40/41€183k€216k▲
Trade receivables40€173k€204k▲
Other amounts receivable41€10k€12k▲
Current investments50/53-€110k
Cash at bank and in hand54/58€184k€114k▼
Deferred charges and accrued income490/1€6k€6k▼
Equity and liabilities
Total equity and liabilities10/49€1.05M€1.08M▲
Equity10/15€593k€624k▲
Contributions10/11€19k€19k=
Reserves13€574k€606k▲
Distributable reserves133€574k€606k▲
Amounts payable17/49€453k€456k▲
Amounts payable after more than one year17€14k€5k▼
Financial debts170/4€14k€5k▼
Amounts payable within one year42/48€440k€451k▲
Current portion of amounts payable after more than one year42€29k€10k▼
Trade debts44€114k€126k▲
Suppliers440/4€114k€126k▲
Taxes, remuneration and social security45€33k€29k▼
Taxes450/3€19k€19k▼
Remuneration and social security454/9€15k€11k▼
Other amounts payable47/48€264k€286k▲
Accrued charges and deferred income492/3-€402
Income statement
Code20242025
Turnover70€2.29M€2.42M▲
Goods, raw materials, services and sundry goods60/61€2.24M€2.28M▲
Remuneration, social security and pensions62€30k€33k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€56k€59k▲
Other operating charges640/8€4k€5k▲
Gross operating margin9900€57k€149k▲
Operating profit (loss)9901€-33k€52k▲
Financial income75/76B€2k€4k▲
Recurring financial income75€2k€4k▲
Financial charges65/66B€22k€21k▼
Recurring financial charges65€22k€21k▼
Profit (loss) for the period before taxes9903€-53k€35k▲
Income taxes67/77€527€4k▲
Profit (loss) for the period9904€-54k€31k▲
Profit (loss) for the period to be appropriated9905€-54k€31k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-54k€31k▲
Transfer from equity791/2€54k-
Transfer to equity691/2-€31k
To other reserves6921-€31k
Social balance
Average headcount (FTE)90870.50.6▲
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
06-05
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Back to profitnet €31k
Net result €31k after one loss-making year.
08-05
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Weakest financial yearnet €-54k ▼294%
Net result drops to €-54k, the lowest in the series; recovery starts the following year.
08-05
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
03-05
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Back to profitnet €9k
Net result €9k after one loss-making year.
02-05
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
29-04
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Highest result since 2018net €74k ▲769%
Operating result €99k, net result €74k, both a record.
04-05
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
27-05
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
15-05
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
15-05
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kortrijk · 2 establishment units since 2002
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Guido Gezellelaan(Heu) 1018501 KortrijkGround area
585 m²
Building footprint
313 m²
Volume, LiDAR
1,387 m³
3 parcels, Flanders · tallest building 11.4 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
Orthoshop Heule
since 20022.095.486.842
Apotheek Dewaele-Ide
since 20172.267.644.719
3 parcels
Flanders
3
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34016C0733/00W004 | Flanders | 284 m² | 1 · 64 m² | 11.1 m · 3 fl. |
| 34016C0733/00V004 | Flanders | 183 m² | 1 · 101 m² | 11.4 m · 3 fl. |
| 34016C0732/00G000 | Flanders | 118 m² | 1 · 148 m² | 2.8 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteKortrijk2.267.644.719
Similar companies · same sector, comparable size
APOTHEEK OLIVIER
BE 0878.810.003
Gingelom · Eq €624k
APOTHEEK ILSE CAUDRON
BE 0878.213.947
Aalst · Eq €625k
PHARMACIE FAIDHERBE
BE 0479.179.208
Frameries · Eq €625k
APOTHEEK VANNESTE TOM
BE 0860.456.811
Kortrijk · Eq €623k
PHARMACIE VOSS-RICHARD
BE 0471.960.131
Verlaine · Eq €622k
Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,273 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-12-2001
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 24 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
4 entriesWebsite:www.apotheekdewaeleide.be
E-mail:apotheek.dewaele-ide@telenet.be
Phone:056 35 60 81
Fax:056 35 77 97